Abstract:Objective To analyze the detection rate of HBV serological makers in non-hepatic inpatients in the past six years. Methods Serum samples of 70 582 non-hepatic inpatients from three large hospitals were collected during 2003 to 2008. Serological markers of HBV ( HBsAg, anti-HBs, HBeAg, antiHBe and anti-HBc) were detected by the AxSYM MEIA system (Abbott Laboratories,Abbott Park,IL).Combining the test results of serological makers with other clinical data, several analysis models for this retrospective study were set up to evaluate the year-to-year changes in serological makers and the detection rates of each model. Results The order from high to low of detection rate of the 5 HBV serological markers was anti-HBc (55. 17% ), anti-HBs (49. 57% ), anti-HBe (28.42%), HBsAg ( 8. 92% ) and HBeAg (2. 12% ), and all of them had a downward trend in the past six years. The positive rate of HBsAg went down from 9. 30% (2003) to 8.70% (2008). The positive rate of HBsAg among people who were born after 1992 (2. 28% ) were significantly lower than that of the overall population (8. 92% ) and fell from 3.57%(2003) to 1.85% (2008). Each detection rate of all serological makers had male sexual side effect [HBsAg ( 12. 38%/7. 25% ), HBeAg ( 2. 72%/1.58% ), anti-HBc ( 56. 57%/53.43% ), anti-HBe (41.50%/28. 35% ) and anti-HBs (65.48%/50. 00% ), male/female]. The differences were statistically significant (Chi-square values of HBsAg, HBeAg, anti-HBc, anti-HBe and anti-HBs were 509.74,105.78, 69.66, 1 321.61 and 1 726.91, respectively; all P ＜ 0. 01).Twenty-six models of HBV serological makers from 70 582 inpatients were summed up, and 8 models had positive rates geater than or equal to 1%. The "All Negative" model ranked No. 1 and had no significant change from year to year. During the past six years, models representing "A11 Negative" and "anti-HBs Positive alone" were mainly in individuals younger than or equal to 20-year-old, while the models representing "anti-HBc and/or anti-HBe,anti-HBs Positive" were mostly in people older than 20-year-old. The distribution curve of models representing "HBsAg, HbeAg and anti-HBc Positive" and "HBsAg, anti-HBc, anti-HBe Positive"etc. showed a bell-shape, covering the population from 20-year-old to 70-year-old. Conclusions The slowlydescending tendency of the detection rates of HBV serological makers was observed during the past six years.The detection rates of HBV in the younger generation decreased significantly. However, the HBV infection rates of overall population is still high, so it is a high time that we made continuous improvement for the serum HBV screening technique in order to reduce the HBV infection ratess.

[Serum Antibody Response to Different Doses of Hepatitis B Vaccine Made by Recombinant DNA Techniques in Yeast and Hansenula Polymorpha Yeast].

Monitoring the Efficacy of Infant Hepatitis B Vaccination and Revaccination in 0- to 8-Year-old Children: Protective Anti-Hbs Levels and Cellular Immune Responses.

Retrospective Analysis of Hepatitis B Virus Serological Markers in 70 582 Inpatients

The Response of Hepatitis B Vaccination on Seronegative Adults with Different Vaccination Schedules.

Longitudinal Mapping of Hepatitis B Vaccine-Induced B-cell Linear Epitopes in Healthy Individuals

Immunological Effects of a 10-Μg Dose of Domestic Hepatitis B Vaccine in Adults

[Cellular Immune Responses of Recombinant Hepatitis B (rhb) Vaccine and HBsAG Derived from Hansenula Polymorpha Cells].

Responses to Hepatitis B Vaccine in Isolated Anti-Hbc Positive Adults.

The One Year Effects of Three Doses of Hepatitis B Vaccine As a Booster in Anti-Hbs-negative Children 11–15 Years after Primary Immunization; China, 2009–2011

Antibody reaction to immunization with recombinant hepatitis B vaccine in undergraduates

Effects of hepatitis B vaccine boosters on anti-HBs-negative children after primary immunization.

Seroprevalence of Hepatitis B and Immune Response to Hepatitis B Vaccination in Chinese College Students Mainly from the Rural Areas of Western China and Born Before HBV Vaccination Integrated into Expanded Program of Immunization.

Comparison of the effect of two different doses of recombinant hepatitis B vaccine on immunogenicity in healthy adults

[Comparison of the Kinesis of Immune Responses in Mice Vaccinated by Different Kinds of Recombinant Hepatitis B Vaccines].

A serological and molecular survey of hepatitis B in children 15 years after inception of the national hepatitis B vaccination program in eastern China.

Immune response following hepatitis B vaccination in infants in Haidian district, Beijing

Suitable Hepatitis B Vaccine for Adult Immunization in China

Immune Response to Hepatitis B Vaccine in Children Born to HBsAg Positive Mothers: a Meta-Regression Analysis

[Study on the Kinesis of Cellular Immunity in Adults Vaccinated with Recombinant Hepatitis B Vaccine].

Evaluation of Hepatitis B Vaccination with Different Dose on Blocking Mother-to-child Transmission

Long-term Persistence of Anti-Hbs after Hepatitis B Vaccination among Isolated Anti-Hbc Positive Adults in China: 8-Years Results